Stock DNA
Pharmaceuticals & Biotechnology
CNY 3,044 Million (Small Cap)
14.00
NA
2.81%
-0.57
8.11%
1.17
Revenue and Profits:
Net Sales:
292 Million
(Quarterly Results - Sep 2025)
Net Profit:
53 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.89%
0%
20.89%
6 Months
29.66%
0%
29.66%
1 Year
59.63%
0%
59.63%
2 Years
100.78%
0%
100.78%
3 Years
10.45%
0%
10.45%
4 Years
32.14%
0%
32.14%
5 Years
116.28%
0%
116.28%
Beijing SDL Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.49%
EBIT Growth (5y)
23.43%
EBIT to Interest (avg)
39.08
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.55
Sales to Capital Employed (avg)
0.55
Tax Ratio
15.26%
Dividend Payout Ratio
92.63%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.17%
ROE (avg)
8.40%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.06
EV to EBIT
7.58
EV to EBITDA
6.16
EV to Capital Employed
1.13
EV to Sales
0.91
PEG Ratio
1.67
Dividend Yield
3.23%
ROCE (Latest)
14.94%
ROE (Latest)
7.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
292.20
260.50
12.17%
Operating Profit (PBDIT) excl Other Income
30.00
16.90
77.51%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
53.40
26.70
100.00%
Operating Profit Margin (Excl OI)
102.60%
26.90%
7.57%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 12.17% vs -15.97% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 100.00% vs -33.42% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,412.10
1,501.20
-5.94%
Operating Profit (PBDIT) excl Other Income
202.50
217.30
-6.81%
Interest
1.70
20.30
-91.63%
Exceptional Items
-10.40
-0.60
-1,633.33%
Consolidate Net Profit
169.60
202.70
-16.33%
Operating Profit Margin (Excl OI)
115.10%
117.40%
-0.23%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -5.94% vs 0.32% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -16.33% vs -28.58% in Dec 2023
About Beijing SDL Technology Co., Ltd. 
Beijing SDL Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






